Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study

Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited. We conducted a case–control study to evaluate the risk of severe complications and mortality following 1–3 doses of CoronaVac and BNT162b2 using ele...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Vincent Ka Chun, Wan, Eric Yuk Fai, Ye, Xuxiao, Mok, Anna Hoi Ying, Lai, Francisco Tsz Tsun, Chui, Celine Sze Ling, Li, Xue, Wong, Carlos King Ho, Li, Philip Hei, Ma, Tiantian, Qin, Simon, Wong, Vincent Kai Chung, Tsang, Tat Chi, Tsui, Sik Hon, Chui, William Chun Ming, Cowling, Benjamin John, Leung, Gabriel Matthew, Lau, Chak Sing, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553171/
https://www.ncbi.nlm.nih.gov/pubmed/35980089
http://dx.doi.org/10.1080/22221751.2022.2114854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553171/
https://www.ncbi.nlm.nih.gov/pubmed/35980089
http://dx.doi.org/10.1080/22221751.2022.2114854

Ejemplares similares